Cargando…
258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C
OBJECTIVES/GOALS: The effect of the Direct-Acting Antiviral (DAA) on hepatic histopathological features from patients treated for HCV has not been thoroughly evaluated. The goals of this retrospective study were to determines differences between the liver biopsies collected before and after DAA trea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129449/ http://dx.doi.org/10.1017/cts.2023.321 |
_version_ | 1785030740127252480 |
---|---|
author | Millian, Daniel Saldarriaga, Omar A. Arroyave, Esteban Wanninger, Timothy Krishnan, Santhoshi Rao, Arvind Moghe, Akshata Stevenson, Heather L. |
author_facet | Millian, Daniel Saldarriaga, Omar A. Arroyave, Esteban Wanninger, Timothy Krishnan, Santhoshi Rao, Arvind Moghe, Akshata Stevenson, Heather L. |
author_sort | Millian, Daniel |
collection | PubMed |
description | OBJECTIVES/GOALS: The effect of the Direct-Acting Antiviral (DAA) on hepatic histopathological features from patients treated for HCV has not been thoroughly evaluated. The goals of this retrospective study were to determines differences between the liver biopsies collected before and after DAA treatment and correlated the histopathology with clinical outcome. METHODS/STUDY POPULATION: Spectral imaging was used to evaluate differences in intrahepatic macrophage (CD68, CD14, CD16, MAC 387, and CD163) and T cell (CD3, CD4, CD8, CD45, and FoxP3) phenotypes in paired liver biopsies collected from the same patient before (n=10) and after (n=10) achieving SVR (Figure 1). Imaging analysis and machine learning algorithms were used to evaluate changes in these key immune cells. We also compared differential gene expression of over 700 genes using RNA isolated from liver biopsies with NanoString. RESULTS/ANTICIPATED RESULTS: Multispectral imaging analysis showed a significant increase of proinflammatory/M1-like (e.g., CD14+) and anti-inflammatory/M2-like macrophage (e.g., CD163+) phenotypes in pre-treatment versus post-treatment biopsies, respectively. Gene expression analysis revealed enrichment of inflammatory (HLA-B, STAT1, CXCL10) and interferon induced-antiviral (ISG15, OAS3, MX1 and IFIT1) genes in the pre-treatment vs the post-treatment group. Cell deconvolution analysis also showed a significant increase of M1-like macrophages in the pre-treatment group when compared to the post-treatment group or controls. Upregulation of genes associated with cell proliferation and differentiation (c-KIT and Fos) was observed in the post-treatment biopsies of patients with persistent inflammatory infiltrates. DISCUSSION/SIGNIFICANCE: Protein and gene expression profiles observed in patients before DAA therapy showed a strong macrophage-mediated inflammatory response against HCV infection in the liver that shifted significantly to a tissue remodeling microenvironment after treatment. |
format | Online Article Text |
id | pubmed-10129449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101294492023-04-26 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C Millian, Daniel Saldarriaga, Omar A. Arroyave, Esteban Wanninger, Timothy Krishnan, Santhoshi Rao, Arvind Moghe, Akshata Stevenson, Heather L. J Clin Transl Sci Precision Medicine/Health OBJECTIVES/GOALS: The effect of the Direct-Acting Antiviral (DAA) on hepatic histopathological features from patients treated for HCV has not been thoroughly evaluated. The goals of this retrospective study were to determines differences between the liver biopsies collected before and after DAA treatment and correlated the histopathology with clinical outcome. METHODS/STUDY POPULATION: Spectral imaging was used to evaluate differences in intrahepatic macrophage (CD68, CD14, CD16, MAC 387, and CD163) and T cell (CD3, CD4, CD8, CD45, and FoxP3) phenotypes in paired liver biopsies collected from the same patient before (n=10) and after (n=10) achieving SVR (Figure 1). Imaging analysis and machine learning algorithms were used to evaluate changes in these key immune cells. We also compared differential gene expression of over 700 genes using RNA isolated from liver biopsies with NanoString. RESULTS/ANTICIPATED RESULTS: Multispectral imaging analysis showed a significant increase of proinflammatory/M1-like (e.g., CD14+) and anti-inflammatory/M2-like macrophage (e.g., CD163+) phenotypes in pre-treatment versus post-treatment biopsies, respectively. Gene expression analysis revealed enrichment of inflammatory (HLA-B, STAT1, CXCL10) and interferon induced-antiviral (ISG15, OAS3, MX1 and IFIT1) genes in the pre-treatment vs the post-treatment group. Cell deconvolution analysis also showed a significant increase of M1-like macrophages in the pre-treatment group when compared to the post-treatment group or controls. Upregulation of genes associated with cell proliferation and differentiation (c-KIT and Fos) was observed in the post-treatment biopsies of patients with persistent inflammatory infiltrates. DISCUSSION/SIGNIFICANCE: Protein and gene expression profiles observed in patients before DAA therapy showed a strong macrophage-mediated inflammatory response against HCV infection in the liver that shifted significantly to a tissue remodeling microenvironment after treatment. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129449/ http://dx.doi.org/10.1017/cts.2023.321 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Precision Medicine/Health Millian, Daniel Saldarriaga, Omar A. Arroyave, Esteban Wanninger, Timothy Krishnan, Santhoshi Rao, Arvind Moghe, Akshata Stevenson, Heather L. 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title | 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title_full | 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title_fullStr | 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title_full_unstemmed | 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title_short | 258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C |
title_sort | 258 analysis of the hepatic microenvironment before and after direct-acting antiviral (daa) therapy for viral hepatitis c |
topic | Precision Medicine/Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129449/ http://dx.doi.org/10.1017/cts.2023.321 |
work_keys_str_mv | AT milliandaniel 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT saldarriagaomara 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT arroyaveesteban 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT wanningertimothy 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT krishnansanthoshi 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT raoarvind 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT mogheakshata 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc AT stevensonheatherl 258analysisofthehepaticmicroenvironmentbeforeandafterdirectactingantiviraldaatherapyforviralhepatitisc |